dalteparin has been researched along with Sjogren's Syndrome in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, R | 1 |
| Gonçalo, M | 1 |
| Tellechea, O | 1 |
| Maia, R | 1 |
| Borges, C | 1 |
| Silva, JA | 1 |
| Figueiredo, A | 1 |
1 other study available for dalteparin and Sjogren's Syndrome
| Article | Year |
|---|---|
Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Topics: Adult; Anticoagulants; Diagnosis, Differential; Enoxaparin; Female; Humans; Injections, Subcutaneous | 2007 |